
Epicore Biosystems Inc Profile last edited on: 5/2/2022
CAGE: 803G3
UEI: TNCHH7GQXHY4
Business Identifier: Wearable microfluidics platform: non-invasively tracking health, wellness, and performance. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
810 Memorial Drive Suite 100
Cambridge, MA 02139
Cambridge, MA 02139
(857) 529-7776 |
info@epicorebiosystems.com |
www.epicorebiosystems.com |
Location: Single
Congr. District: 07
County: Middlesex
Congr. District: 07
County: Middlesex
Public Profile
Epicore Biosystems - a relative newcomer to the SBIR arena - is structured around development of a wearable microfluidics platform that non-invasively tracks health, wellness, and performance: personalized hydration and metabolic health. The approach is anchored in tracking the biochemical/digital biomarkers that underpin performance and health by utilizing wearable microfluidic sensors. Describing one aspect of what the firm does involves a product enabling athletes to optimize hydration and refuel after exercise, Epicore Biosystems Inc has developed a proprietary sweat microfluidic sensing platform that is skin-like, low-cost, and capable of analyzing small droplets of sweat directly from the skin. Designated the Gx Sweat Patch, the leading product is a wearable patch that - paired with an easy-to-use software app - in real time provides the User personalized recommendations re. optimizing hydration after exercise. Anchored in over two decades of microfluidic and soft materials research in Prof. John Rogers'? Laboratory at Northwestern University's Center for Bio-Integrated Electronics, Epicore Biosystems is reported as having recently signed a partnership with a leading Fortune 100 global brand to commercialize the first-ever, single-use sweat analytics system for athletes. The companys sweat microfluidic platform has been deployed with professional sports teams (NBA, NFL, and MLB), military research labs, and across multiple clinical study programs, including stroke, skin health, stress, fatigue, and kidney health.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
20-24Revenue Range
2M-2.5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
10-14Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2022 | 1 | NIH | $299,936 | |
Project Title: Wearable Microfluidic Systems for Measuring Sweat Biomarkers in Cystic Fibrosis Patients During Exercise in Remote Settings | ||||
2020 | 1 | NIH | $251,695 | |
Project Title: Soft, Epidermal Biosystems with Advanced Sensing and Microfluidics Capabilities for Assessing Fatigability Biomarkers |
Key People / Management
Roozbeh Ghaffari -- Founder and
Alexander Aranyosi -- Chief Scientific Officer, SVP Research and Digital Science Co-Founder
Stephen P Lee -- Chief Technology Officer, SVP Technology Co-Founder
Weihua Li -- Senior Vice President, Software Engineering
Jeff Model -- Co-Founder, Chief Product Officer
John Rogers -- Advisor, Co-Founder
Don Wright -- Director, Translational Research and Development
John Wright -- Chief Operating Officer, SVP Translational Research and Development
Alexander Aranyosi -- Chief Scientific Officer, SVP Research and Digital Science Co-Founder
Stephen P Lee -- Chief Technology Officer, SVP Technology Co-Founder
Weihua Li -- Senior Vice President, Software Engineering
Jeff Model -- Co-Founder, Chief Product Officer
John Rogers -- Advisor, Co-Founder
Don Wright -- Director, Translational Research and Development
John Wright -- Chief Operating Officer, SVP Translational Research and Development